Literature DB >> 2001331

Characterization of binding proteins from ovarian carcinoma and kidney tubule cells that are specific for cisplatin modified DNA.

P A Andrews1, J A Jones.   

Abstract

We have detected proteins in nuclear extracts from ovarian carcinoma cells and kidney tubule cells that bind specifically to platinated DNA. A 123-bp restriction fragment was platinated with cisplatin (DDP) to a formal molar platinum to nucleotide ratio of 0.05 and end-labeled with [32P]-dCTP. Incubation with nuclear extracts from 2008 human ovarian carcinoma cells caused shifts in the mobility of this probe in non-denaturing polyacrylamide gels. Proteinase K, but not ribonuclease A, destroyed the bands. Comparison of the shifted bands generated by DDP-resistant 2008 and A2780 human ovarian carcinoma cell nuclear extracts with bands from the corresponding sensitive cells showed no differences in protein levels. The affinity of the proteins for the probe was the same in sensitive and resistant 2008 nuclear extracts as determined by competition with platinated salmon sperm DNA. These proteins also bound to a probe damaged with 1,2-diaminocyclohexaneplatinum(II) dichloride but did not bind to a trans-DDP platinated probe. No differences were found in the levels of UV4 or UV5 Chinese hamster ovary cells, which were hypersensitive to DDP compared to wild-type AA8 cells. MDCK and LLC-PK1 kidney tubule cells, which were more resistant to DDP cytotoxicity than 2008 cells, exhibited decreased levels of these proteins. We conclude that, although these proteins that recognize DDP damage in DNA may be involved in excision repair, their levels did not correlate with DDP sensitivity in this panel of cell lines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001331     DOI: 10.3727/095535491820873524

Source DB:  PubMed          Journal:  Cancer Commun        ISSN: 0955-3541


  5 in total

1.  NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement.

Authors:  Arin B Aurora; Aryn B Aurora; Dauren Biyashev; Yelena Mirochnik; Tetiana A Zaichuk; Cristina Sánchez-Martinez; Marie-Ange Renault; Douglas Losordo; Olga V Volpert
Journal:  Blood       Date:  2010-03-04       Impact factor: 22.113

2.  Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis.

Authors:  Alison L Greenway; Dale A McPhee; Kelly Allen; Ricky Johnstone; Gavan Holloway; John Mills; Ahmed Azad; Sonia Sankovich; Paul Lambert
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo.

Authors:  J S Mymryk; E Zaniewski; T K Archer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

4.  Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.

Authors:  Diana Trentin; Heike Hall; Sandra Wechsler; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

5.  A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells.

Authors:  Gaetano Marverti; Gaia Gozzi; Eleonora Maretti; Angela Lauriola; Leda Severi; Francesca Sacchetti; Lorena Losi; Salvatore Pacifico; Stefania Ferrari; Glauco Ponterini; Eliana Leo; Maria Paola Costi; Domenico D'Arca
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.